Clinical trial
Prognostic Implications of AccuFFRangio-based Functional Evaluation for Guiding Coronary Intervention for Non-IRA Stenosis in Patients With STEMI
NCT05209503 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Implications of AccuFFRangio-based Functional Evaluation for Guiding Coronary Intervention for Non-IRA Stenosis in Patients With STEMI
- Lead sponsor
- Wuhan Asia Heart Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 15, 2022
- Completion date
- May 31, 2023
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.